Loading insider details...
Beta
Latest Form 4 (Jun 15, 2026): Grant/Award of 8,325 TGTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 8,325 | n/a |
| Jun 12, 2026 | Nuvectis Pharma, Inc. (NVCT) | Grant/Award | 35,000 | n/a |
| Jun 16, 2025 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 14,718 | n/a |
| Jun 12, 2025 | Nuvectis Pharma, Inc. (NVCT) | Grant/Award | 30,000 | n/a |
| Jun 20, 2024 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 22,250 | n/a |
| Jun 13, 2024 | Nuvectis Pharma, Inc. (NVCT) | Grant/Award | 30,000 | n/a |
| Sep 29, 2023 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 20,000 | n/a |
| Jun 20, 2023 | Nuvectis Pharma, Inc. (NVCT) | Grant/Award | 18,000 | n/a |
| Jul 22, 2022 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 43,732 | n/a |
| May 16, 2022 | Nuvectis Pharma, Inc. (NVCT) | Purchase | 6,000 | $104.4K |